Oral calcium tolerance test in the early diagnosis of primary hyperparathyroidism and multiple endocrine neoplasia type 1 in patients with the Zollinger-Ellison syndrome

Gut

Volumn 39, Issue 2, 1996, Pages 273-278

  Cadiot, G ^a   Houillier, P ^b   Allouch, A ^a   Paillard, M ^b   Mignon, M ^a  

^a BICHAT HOSPITAL   (France)

^b SORBONNE UNIVERSITÉ   (France)

Author keywords

Calcium; Multiple endocrine neoplasia type 1; Parathyroid hormone; Primary hyperparathyroidism; Zollinger Ellison syndrome

Indexed keywords

CALCIUM LACTOBIONATE; GLUCONATE CALCIUM; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CALCIUM METABOLISM; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EARLY DIAGNOSIS; FEMALE; HUMAN; MALE; MULTIPLE ENDOCRINE NEOPLASIA; ORAL DRUG ADMINISTRATION; PARATHYROID FUNCTION; PRIMARY HYPERPARATHYROIDISM; PRIORITY JOURNAL; ZOLLINGER ELLISON SYNDROME;

EID: 0029833105     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.39.2.273     Document Type: Article

References (22)

1. Mignon M, Cadiot G, Rigaud D, Ruszniewski Ph, Jaïs P, Lehy T, et al. Management of islet cell tumors in patients with multiple endocrine neoplasia type 1. In: Mignon M, Jensen RT, eds. Endocrine tumors of the pancreas. Recent advances in research and management. Front Gastrointest Res Basel: Karger, 1995; 23: 342-59.
2. Jensen RT, Gardner JD, Gastrinoma. In: Go VLW, DiMagno EP, Gardner JD, Lebenthal E, Reber HA, Scheele GA, eds. The pancreas: biology, pathobiology, and disease. 2nd ed. New York: Raven Press, 1993: 931-78.
3. Ruszniewski Ph, Podevin Ph, Cadiot G, Marmuse JP, Mignon M, Vissuzaine C, et al. Clinical, anatomical, and evolutive features of patients with the Zollinger-Ellison syndrome combined with type 1 multiple endocrine neoplasia. Pancreas 1993; 8: 295-304.
4. Lamers CBHW. Gastrinoma in multiple endocrine neoplasia type 1. Acta Oncol 1991; 30: 489-92.
5. Farley DR, Van Hoerden JA, Grant CS, Miller LJ, Ilstrup DM. The Zollinger-Ellison syndrome. A collective surgical experience. Ann Surg 1992; 215: 561-70.
6. Benya RV, Metz DC, Venzon DJ, Fishbeyn VA, Strader DB, Orbuch M, et al. Zollinger-Ellison syndrome can be the initial endocrine manifestation in patients with multiple endocrine neoplasia-type 1. Am J Med 1994; 97: 436-44.
7. Melvin WS, Johnson JA, Sparks J, Innes JT, Ellison EC. Long-term prognosis of Zollinger-Ellison syndrome in multiple endocrine neoplasia. Surgery 1993; 114: 1183-8.
8. Sheppard BC, Norton JA, Doppman JL, Maton PN, Gardner JD, Jensen RT. Management of islet cell tumors in patients with multiple endocrine neoplasia (MEN): a prospective study. Surgery 1989; 106: 1108-11.
9. Andersen DK. Current diagnosis and management of Zollinger-Ellison syndrome. Ann Surg 1989; 210: 685-703.
10. Thompson NW, Bondeson AG, Bondeson L, Vinik A. The surgical treatment of gastrinoma in MEN I syndrome patients. Surgery 1989; 106: 1081-6.
11. Norton JA, Doppman JL, Cornelius MJ, Maton P, Gardner JD, Jensen RT. Effects of parathyroidectomy in patients with hyperparathyroidism and Zollinger-Ellison syndrome and multiple endocrine neoplasia type 1. Surgery 1987; 102: 958-66.
12. Skogseid B, Öberg K. Genetics of multiple endocrine neoplasia type 1. In: Mignon M, Jensen RT, eds. Endocrine tumors of the pancreas. Recent advances in research and management. Front Gastrointest Res. Basel: Karger, 1995; 23: 60-9.
13. Broadus AE, Horst RL, Littledike ET, Mahaffey JE, Rasmussen H. Primary hyperparathyroidism with intermittent hypercalcemia: serial observations and simple diagnosis by means of an oral calcium tolerance test. Clin Endocrinol 1980; 12: 225-35.
14. Gardin JP, Paillard M. Normocalcemic primary hyperparathyroidism: resistance to PTH effect on tubular reabsorption of calcium. Miner Electrolyte Metab 1984; 10: 301-8.
15. Monchik JM, Lamberton RP, Roth U. Role of the oral calcium-loading test with measurement of intact parathyroid hormone in the diagnosis of symptomatic subtle primary hyperparathyroidism. Surgery 1992; 112: 1103-10.
16. Yendt ER, Gagne RJA. Detection of primary hyperparathyroidism, with special reference to its occurrence in hypercalciuric females with 'normal' or borderline serum calcium. Can Med Ass J 1968; 98: 331-6.
17. Patron P, Gardin JP, Paillard M. Renal mass and reserve of vitamin D: determinants in primary hyperparathyroidism. Kidney Int 1987; 31: 1174-80.
18. Nussbaum SR, Zahradnik RJ, Lavigne JR, Brennan GL, Nozawa-Ung K, Kim LY, et al. Highly sensitive two-site immunoradiometric assay of parathyrin and its clinical utility in evaluating patients with hypercalcemia. Clin Chem 1987; 33: 1364-7.
19. Mignon M, Bonfils S. Diagnosis and treatment of Zollinger-Ellison syndrome. Bailleres Clin Gastroenterol 1988; 2: 677-98.
20. Broadus AE, Mahaffey JE, Bartter FC, Neer RM. Nephrogenous cyclic adenosine monophosphate as a parathyroid function test. J Clin Invest 1977; 60: 771-83.
21. Strewler GJ, Rosenblatt M. Mineral metabolism. In: Felig P, Baxter JD, Frohman LA, eds. Endocrinology and metabolism. New York: McGraw-Hill, 1995: 1407-516.
22. Deftos LJ, Catherwood BD, Bone III HG. Multiglandular endocrine disorders. In: Felig P, Baxter JD, Frohman LA, eds. Endocrinology and metabolism. New York: McGraw-Hill, 1995: 1703-32.